✦ LIBER ✦

Results of U.S. phase I and II clinical trials of transcatheter closure of patent ductus arteriosus in adult patients using the amplatzerfi duct occlud

✍ Scribed by Tom Hong; Ziyad M. Hijazi; William E. Hellenbrand; John P. Cheatham; Zahid Amin; Thomas K. Jones

Book ID: 119546466
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 182 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)80938-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the Phase I Food and Drug Adm

Results of the Phase I Food and Drug Administration clinical trial of duct-occlud device occlusion of patent ductus arteriosus

✍ John W. Moore; Doreen DiMeglio; Alexander P. Javois; Masato Takahashi; Farhouch 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Results of U.S. phase I clinical trial o

Results of U.S. phase I clinical trial of closure of patent foramen ovale associated with stroke/transient ischemic attack or peripheral embolism using the amplatzerfi patent foramen ovale device

✍ Tom Hong; Ziyad M. Hijazi; Donald J. Hagler; Hitendra Patel; John P. Cheatham; L 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Transcatheter closure of patent foramen

Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate-term results of the U.S. multicenter clinical trial

✍ Thomas E. Hong; David Thaler; James Brorson; Mary Heitschmidt; Ziyad M. Hijazi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

## Abstract Closure of patent foramen ovale (PFO) has been proposed as an alternative to anticoagulation in patients with presumed paradoxical emboli. We report the immediate and mid‐term results of the phase 1 U.S. Multicenter Clinical Trial of patients who underwent transcatheter PFO closure for